Ole Kirk
Ole Kirk
Unknown affiliation
Verified email at
Cited by
Cited by
Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study
Data Collection on Adverse Events of Anti-HIV Drugs Study Group
Archives of internal medicine 166 (15), 1632-1641, 2006
Cardiovascular disease risk factors in HIV patients–association with antiretroviral therapy. Results from the DAD study
N Friis-Møller, R Weber, P Reiss, R Thiťbaut, O Kirk, AA Monforte, ...
Aids 17 (8), 1179-1193, 2003
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D: A: D): a multicohort collaboration
CJ Smith, L Ryom, R Weber, P Morlat, C Pradier, P Reiss, JD Kowalska, ...
The Lancet 384 (9939), 241-248, 2014
Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse†…
SW Worm, C Sabin, R Weber, P Reiss, W El-Sadr, F Dabis, S De Wit, ...
The Journal of infectious diseases 201 (3), 318-330, 2010
Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort
D Konopnicki, A Mocroft, S De Wit, F Antunes, B Ledergerber, C Katlama, ...
Aids 19 (6), 593-601, 2005
Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy
JK Rockstroh, A Mocroft, V Soriano, C Tural, MH Losso, A Horban, O Kirk, ...
The Journal of infectious diseases 192 (6), 992-1002, 2005
Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe
A Mocroft, O Kirk, SE Barton, M Dietrich, R Proenca, R Colebunders, ...
Aids 13 (8), 943-950, 1999
Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients
A Mocroft, O Kirk, P Reiss, S De Wit, D Sedlacek, M Beniowski, J Gatell, ...
Aids 24 (11), 1667-1678, 2010
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study
N Friis-Møller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ...
European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?
E Fontas, F Van Leth, CA Sabin, N Friis-Møller, M Rickenbach, ...
The Journal of infectious diseases 189 (6), 1056-1074, 2004
Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study†…
A Mocroft, JD Lundgren, ML Sabin, AA Monforte, N Brockmeyer, ...
PLoS medicine 10 (9), e1001510, 2013
HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load
AN Phillips, S Staszewski, R Weber, O Kirk, P Francioli, V Miller, ...
Jama 286 (20), 2560-2567, 2001
Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Studya
L Ryom, A Mocroft, O Kirk, SW Worm, DA Kamara, P Reiss, M Ross, ...
The Journal of infectious diseases 207 (9), 1359-1369, 2013
Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy
O Kirk, C Pedersen, A Cozzi-Lepri, F Antunes, V Miller, JM Gatell, ...
Blood, The Journal of the American Society of Hematology 98 (12), 3406-3412, 2001
Serious fatal and nonfatal non-AIDS-defining illnesses in Europe
A Mocroft, P Reiss, J Gasiorowski, B Ledergerber, J Kowalska, A Chiesi, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (2), 262-270, 2010
Changing incidence of central nervous system diseases in the EuroSIDA cohort
A d'Arminio Monforte, P Cinque, A Mocroft, FD Goebel, F Antunes, ...
Annals of Neurology: Official Journal of the American Neurological†…, 2004
Influence of age on CD4 cell recovery in human immunodeficiency virus–infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study
JP Viard, A Mocroft, A Chiesi, O Kirk, B Røge, G Panos, N Vetter, ...
The Journal of infectious diseases 183 (8), 1290-1294, 2001
All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort†…
Collaboration of Observational HIV Epidemiological Research Europe (COHERE ...
International journal of epidemiology 41 (2), 433-445, 2012
Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection
GJ Weverling, A Mocroft, B Ledergerber, O Kirk, J Gonzales-Lahoz, ...
The Lancet 353 (9161), 1293-1298, 1999
Chronic renal failure among HIV-1-infected patients
A Mocroft, O Kirk, J Gatell, P Reiss, P Gargalianos, K Zilmer, M Beniowski, ...
Aids 21 (9), 1119-1127, 2007
The system can't perform the operation now. Try again later.
Articles 1–20